US Patent 10023635 Antibodies to ICOS
Patent 10023635 was granted and assigned to Jounce Therapeutics, Inc. on July, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10023635 Antibodies to ICOS
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.